Literature DB >> 22407695

Radiofrequency ablation: technique and clinical applications.

Servet Tatli1, Umit Tapan, Paul R Morrison, Stuart G Silverman.   

Abstract

Radiofrequency ablation is the most commonly used percutaneous ablation technique and well-documented in the literature on focal therapies. It has become the image-guided ablation method of choice because of its efficacy, safety, and ease of use. Radiofrequency ablation has shown promise in treating selected solid tumors, particularly those involving the liver, kidneys, lungs, and the musculoskeletal system. It is a minimally invasive technique often used in inoperable patients with other comorbidities. Radiofrequency ablation requires a minimal hospital stay or can be performed on an outpatient basis. The aim of this article is to review radiofrequency ablation techniques and their clinical applications.

Entities:  

Mesh:

Year:  2012        PMID: 22407695     DOI: 10.4261/1305-3825.DIR.5168-11.1

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  22 in total

1.  Risk of burn trauma during circumcision with radiofrequency scalpel: case report and review of literature.

Authors:  Ali Akbar Mohammadi; Seyed Morteza Seyed Jafari; Ahmad Abdollahi
Journal:  Int J Burns Trauma       Date:  2013-07-08

2.  Discontinuous moving shot technique for conformal thermal ablation in an ex vivo porcine liver model.

Authors:  Ge Ma; Hao Chen; Jin Xu; Hong Pan; Muxin Yu; Yue Wang; Hui Xie; Wenbin Zhou; Shui Wang
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

3.  Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.

Authors:  Anna Maria Ierardi; Alessio Puliti; Salvatore Alessio Angileri; Mario Petrillo; Ejona Duka; Chiara Floridi; Michela Lecchi; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2017-04-19       Impact factor: 3.064

Review 4.  Treatment of focal benign lesions of the bone: MRgFUS and RFA.

Authors:  Carlo Masciocchi; Francesco Arrigoni; Alice La Marra; Silvia Mariani; Luigi Zugaro; Antonio Barile
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

5.  Percutaneous Cholecystostomy and Hydrodissection in Radiofrequency Ablation of Liver Subcapsular Leiomyosarcoma Metastasis Adjacent to the Gallbladder: Protective Effect.

Authors:  André Azevedo; Priscila Falsarella; Rafael Rocha; Antônio Rahal; Rodrigo Garcia
Journal:  J Radiol Case Rep       Date:  2016-10-31

Review 6.  MRI of hepatocellular carcinoma: an update of current practices.

Authors:  Hina Arif-Tiwari; Bobby Kalb; Surya Chundru; Puneet Sharma; James Costello; Rainner W Guessner; Diego R Martin
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

7.  Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.

Authors:  Okan Akhan; Ezgi Güler; Devrim Akıncı; Türkmen Çiftçi; Ilgaz Çağatay Köse
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

8.  Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.

Authors:  Filippo Scopelliti; Antonio Pea; Rita Conigliaro; Giovanni Butturini; Isabella Frigerio; Paolo Regi; Alessandro Giardino; Helga Bertani; Marina Paini; Paolo Pederzoli; Roberto Girelli
Journal:  Surg Endosc       Date:  2018-05-15       Impact factor: 4.584

9.  Laparoscopic repair of a diaphragmatic hernia associated with radiofrequency ablation for hepatocellular carcinoma: lessons from a case and the review of the literature.

Authors:  Ryohei Nomura; Hiromi Tokumura; Makoto Furihata
Journal:  Int Surg       Date:  2014 Jul-Aug

Review 10.  Microwave ablation of renal tumors: state of the art and development trends.

Authors:  Chiara Floridi; Irene De Bernardi; Federico Fontana; Alessandra Muollo; Anna Maria Ierardi; Andrea Agostini; Paolo Fonio; Ettore Squillaci; Luca Brunese; Carlo Fugazzola; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2014-07-08       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.